After having been one of the biggest gainers some a week or so ago, the Regen BioPharma Inc (OTCMKTS:RGBP) stock seems to be in the middle of another upward move.
Although there has been no news about the company this morning, the Regen stock has climbed by 37%. In light of such gains, it might be a good move for investors to possibly take a look at the remarkable rally in the stock not too long ago.
Back in mid-April, the stock managed to record gains of 3800% in only three trading sessions after Regen announced that it managed to bag a licensing deal for its pancreatic cancer treatment. Following the announcement, in addition to the strong rally, the trading volumes went through the roof as well.
However, at the same time, it is also necessary to remember that after a few days, the RGBP stock also displayed considerable volatility. After today’s rally, the stock might be back in focus among many investors.